Reference Kidney Sample Collection
Nicholas Lucarelli
Published: 2023-10-26 DOI: 10.17504/protocols.io.e6nvwdo6dlmk/v1
Abstract
Inclusion:
- Minimal pathologic changes
Exclusion:
- Evidence of hydronephrosis
- Evidence of infectious disease
- Proteinuria
- Image artifacts
-
5% Interstitial Fibrosis and Tubular Atrophy (IFTA)
Steps
Sample Collection
1.
Patient samples will be obtained from human kidneys, using nephrectomies from renal cancer patients. Tissue sections will be uninvolved and away from tumor areas. Sections will be screened by a pathologist to ensure minimal pathologic changes, and minimal image artifacts.
2.
Inclusion/Exclusion Criteria:
Inclusion:
- Minimal pathologic changes
Exclusion:
- Evidence of hydronephrosis
- Evidence of infectious disease
- Proteinuria
- Image artifacts
-
5% Interstitial Fibrosis and Tubular Atrophy (IFTA)
